Twelve New ICD-10-PCS Hospital Procedure Codes Released for COVID-19 Treatment

Twelve New ICD-10-PCS Hospital Procedure Codes Released for COVID-19 Treatment – AHIMA and AHA Update FAQs

 

The unprecedented events of the COVID-19 pandemic have resulted in another unprecedented event: the release of new ICD-10-PCS codes that will be put in use immediately – effective with discharges on or after August 1, 2020, rather than the usual effective date of October 1 (CMS, 2020). Immediate reporting of the new hospital procedure codes for COVID-19 will allow for tracking of the use and effectiveness of these therapies in treating inpatients for COVID-19 and provide valuable information as the nation continues to deal with the disease.

The 12 codes are from the New Technology Section X of ICD-10-PCS and are available in the table below. Codes are available for the introduction or infusion of Remdesivir, Sarilumab, Tocilizumab, or other therapeutic substances, as well as the transfusion of convalescent plasma specifically for the treatment of COVID-19.

Code Description
XW033E5 Introduction of Remdesivir Anti-Infective into Peripheral Vein, Percutaneous Approach New Technology Group 5
XW043E5 Introduction of Remdesivir Anti-Infective into Central Vein, Percutaneous Approach New Technology Group 5
XW033G5 Introduction of Sarilumab Anti-Infective into Peripheral Vein, Percutaneous Approach New Technology Group 5
XW043G5 Introduction of Sarilumab Anti-Infective into Central Vein, Percutaneous Approach New Technology Group 5
XW033H5 Introduction of Tocilizumab Anti-Infective into Peripheral Vein, Percutaneous Approach New Technology Group 5
XW043H5 Introduction of Tocilizumab Anti-Infective into Central Vein, Percutaneous Approach New Technology Group 5
XW013F5 Introduction of Other New Technology Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach New Technology Group 5
XW033F5 Introduction of Other New Technology Therapeutic Substance into Peripheral Vein, Percutaneous Approach New Technology Group 5
XW043F5 Introduction of Other New Technology Therapeutic Substance into Central Vein, Percutaneous Approach New Technology Group 5
XW0DXF5 Introduction of Other New Technology Therapeutic Substance into Mouth or Pharynx, External Approach New Technology Group 5
XW13325 Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach New Technology Group 5
XW14325 Transfusion of Convalescent Plasma (Nonautologous) into Central Vein, Percutaneous Approach New Technology Group 5

 

annual medical coding updatesNote that these new ICD-10-PCS codes 2020 apply to inpatient admissions and should only be used to reflect treatment for COVID-19. Codes from sections other than New Technology, such as the Administration section, should be used if the treatment is not specifically for COVID-19. MS-DRG assignment will not be affected by the reporting of these new COVID-19 treatment codes.

The “Frequently Asked Questions Regarding ICD-10-CM/PCS Coding For COVID-19” document prepared by AHIMA and AHA has also been updated (AHA Coding Clinic Advisor, 2020). There are now a total of 42 questions with recommended coding for each. The last five questions discuss the new COVID-19 ICD-10-PCS codes just released. Other topics in the revised document include coding for re-admissions of COVID-19 patients, sequela and personal history of COVID-19 and multisystem inflammatory syndrome (MIS-C) due to COVID-19.

Note that some of the original questions and answers have been revised, the most current version is v11. Revision dates, if applicable, are noted in the FAQ document.

AMA released the CPT code 87426 for antigen testing in June 2020. Review our COVID-19 Explained article series, which dives into how to code the screening for suspected COVID-19 infection, how to code possible infection and symptoms, and the history and background on COVID-19.

Review these additional articles for COVID-19 coding and reporting information:

Teri Jorwic

Contract Educator, MPH, RHIA, CCS, CCS-P, FAHIMA
new hospital procedure codes for covid-19

Subscribe to our Newsletter

HOW CAN WE HELP? LET’S DISCUSS!

  • By clicking Download Now, you agree to YES HIM Consulting's Privacy Policy and Terms of Use.